Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

α-Synuclein disrupts the anti-inflammatory role of Drd2 via interfering β-arrestin2-TAB1 interaction in astrocytes
Ren‐Hong Du, Yan Zhou, Meiling Xia, et al.
Journal of Neuroinflammation (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Tumor suppressor DRD2 facilitates M1 macrophages and restricts NF-κB signaling to trigger pyroptosis in breast cancer
Yiqing Tan, Ran Sun, Lei Liu, et al.
Theranostics (2021) Vol. 11, Iss. 11, pp. 5214-5231
Open Access | Times Cited: 117
Metformin normalizes mitochondrial function to delay astrocyte senescence in a mouse model of Parkinson’s disease through Mfn2-cGAS signaling
Min Wang, Tian Tian, Zhou Hong, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Astragaloside IV inhibits astrocyte senescence: implication in Parkinson’s disease
Meiling Xia, Xia‐Hong Xie, Jianhua Ding, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 95
Gut Inflammation in Association With Pathogenesis of Parkinson’s Disease
Qian-Qian Chen, Caroline Haikal, Wen Li, et al.
Frontiers in Molecular Neuroscience (2019) Vol. 12
Open Access | Times Cited: 77
Fibrillar α-synuclein induces neurotoxic astrocyte activation via RIP kinase signaling and NF-κB
Tsui-Wen Chou, Nydia Chang, Medha Krishnagiri, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 8
Open Access | Times Cited: 60
The role of dopamine in NLRP3 inflammasome inhibition: Implications for neurodegenerative diseases
Elena Possemato, Livia La Barbera, Annalisa Nobili, et al.
Ageing Research Reviews (2023) Vol. 87, pp. 101907-101907
Closed Access | Times Cited: 39
The cGAS-STING-YY1 axis accelerates progression of neurodegeneration in a mouse model of Parkinson’s disease via LCN2-dependent astrocyte senescence
Siyuan Jiang, Tian Tian, Hang Yao, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 10, pp. 2280-2292
Closed Access | Times Cited: 27
The modulatory role of dopamine receptors in brain neuroinflammation
Qing-Peng Xia, Zhao-Yan Cheng, Ling He
International Immunopharmacology (2019) Vol. 76, pp. 105908-105908
Closed Access | Times Cited: 65
Kir6.1/K-ATP channel on astrocytes protects against dopaminergic neurodegeneration in the MPTP mouse model of Parkinson’s disease via promoting mitophagy
Zhaoli Hu, Ting Sun, Ming Lu, et al.
Brain Behavior and Immunity (2019) Vol. 81, pp. 509-522
Open Access | Times Cited: 62
Astrocyte dysfunction in Parkinson's disease: from the perspectives of transmitted α-synuclein and genetic modulation
Changjing Wang, Tongtong Yang, Meiyu Liang, et al.
Translational Neurodegeneration (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 47
Acrolein-mediated neuronal cell death and alpha-synuclein aggregation: Implications for Parkinson's disease
A. Ambaw, Lingxing Zheng, Mitali A. Tambe, et al.
Molecular and Cellular Neuroscience (2018) Vol. 88, pp. 70-82
Closed Access | Times Cited: 50
Astrocytic Kir6.1 deletion aggravates neurodegeneration in the lipopolysaccharide-induced mouse model of Parkinson’s disease via astrocyte-neuron cross talk through complement C3-C3R signaling
Miaomiao Chen, Zhaoli Hu, Jianhua Ding, et al.
Brain Behavior and Immunity (2021) Vol. 95, pp. 310-320
Closed Access | Times Cited: 34
Electroacupuncture Attenuates Neuropathic Pain and Comorbid Negative Behavior: The Involvement of the Dopamine System in the Amygdala
Xuehui Zhang, Chenchen Feng, Lijian Pei, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 33
Transfer of neuron-derived α-synuclein to astrocytes induces neuroinflammation and blood–brain barrier damage after methamphetamine exposure: Involving the regulation of nuclear receptor-associated protein 1
Jian Huang, Jiuyang Ding, Xiaohan Wang, et al.
Brain Behavior and Immunity (2022) Vol. 106, pp. 247-261
Closed Access | Times Cited: 25
Role of transcription factors, noncoding RNAs, epitranscriptomics, and epigenetics in post‐ischemic neuroinflammation
Suresh L. Mehta, Vijay Arruri, Raghu Vemuganti
Journal of Neurochemistry (2024)
Open Access | Times Cited: 5
Cerebellar Heterogeneity and Selective vulnerability in Spinocerebellar Ataxia Type 1 (SCA1)
Katherine Hamel, Francisco Emmanuel Labrada-Moncada, Carrie Sheeler, et al.
Neurobiology of Disease (2024) Vol. 197, pp. 106530-106530
Open Access | Times Cited: 5
Antidepressant-like effect of pramipexole in an inflammatory model of depression
Vicente Lieberknecht, Maurício P. Cunha, Stella C. Junqueira, et al.
Behavioural Brain Research (2016) Vol. 320, pp. 365-373
Closed Access | Times Cited: 40
Dopamine activates NF-κB and primes the NLRP3 inflammasome in primary human macrophages
Rachel Nolan, Katelyn Reeb, Yongzhang Rong, et al.
Brain Behavior & Immunity - Health (2019) Vol. 2, pp. 100030-100030
Open Access | Times Cited: 36
Drd2 biased agonist prevents neurodegeneration against NLRP3 inflammasome in Parkinson’s disease model via a β-arrestin2-biased mechanism
Jialei Zhu, Ting Sun, Jing Zhang, et al.
Brain Behavior and Immunity (2020) Vol. 90, pp. 259-271
Closed Access | Times Cited: 36
Dopamine, a co-regulatory component, bridges the central nervous system and the immune system
Mingan Li, Lin Zhou, Xiaohui Sun, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112458-112458
Open Access | Times Cited: 32
Arrestin beta‐2 deficiency exacerbates periodontal inflammation by mediating activating transcription factor 6 activation and abnormal remodelling of the extracellular matrix
Meiting Feng, Ruiling Wang, Li Deng, et al.
Journal Of Clinical Periodontology (2024) Vol. 51, Iss. 6, pp. 742-753
Closed Access | Times Cited: 4
Tetramethylpyrazine Analogue T-006 Promotes the Clearance of Alpha-synuclein by Enhancing Proteasome Activity in Parkinson’s Disease Models
Hefeng Zhou, Min Shao, Baojian Guo, et al.
Neurotherapeutics (2019) Vol. 16, Iss. 4, pp. 1225-1236
Open Access | Times Cited: 34
Pharmacological and chemogenetic orexin/hypocretin intervention ameliorates Hipp-dependent memory impairment in the A53T mice model of Parkinson’s disease
Miloš Stanojlović, Jean Pierre Pallais, Michael K. Lee, et al.
Molecular Brain (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 30
Dopaminergic Signaling as a Plausible Modulator of Astrocytic Toll-Like Receptor 4: A Crosstalk between Neuroinflammation and Cognition
Madhavan Nampoothiri, Prasada Chowdari Gurram, Suman Manandhar, et al.
CNS & Neurological Disorders - Drug Targets (2022) Vol. 22, Iss. 4, pp. 539-557
Closed Access | Times Cited: 17
Alpha-synuclein fine-tunes neuronal response to pro-inflammatory cytokines
Veronika Sigutova, Wei Xiang, Martin Regensburger, et al.
Brain Behavior and Immunity (2024) Vol. 122, pp. 216-230
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top